UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Journal of the American College of Cardiology, 2014-11, Vol.64 (20), p.2101-2108

2014

Volltextzugriff (PDF)

suPAR: A New Biomarker for Cardiovascular Disease?

Canadian journal of cardiology, 2015-10, Vol.31 (10), p.1293-1302

2015

Volltextzugriff (PDF)

Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy

JACC. Cardiovascular imaging, 2010-06, Vol.3 (6), p.555-562

2010

Volltextzugriff (PDF)

Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial

The American journal of cardiology, 2010-06, Vol.105 (12), p.1802-1808

2010

Volltextzugriff (PDF)

When to Operate: Severe Aortic Stenosis Is Still a Clinical Enigma

The American journal of cardiology, 2013-11, Vol.112 (9), p.1510-1511

Wachtell, Kristian, MD, PhD, DrMedSci

2013

Volltextzugriff (PDF)

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

The American journal of cardiology, 2015-12, Vol.116 (12), p.1840-1844

2015

Volltextzugriff (PDF)

Structural and Functional Cardiac Changes Are Target Organ Damage That Increases Risk of Atrial Fibrillation

Journal of the American College of Cardiology, 2014-05, Vol.63 (19), p.2014-2015

2014

Volltextzugriff (PDF)

Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)

The American journal of cardiology, 2010-10, Vol.106 (7), p.999-1005

2010

Volltextzugriff (PDF)

Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study)

The American journal of cardiology, 2010-12, Vol.106 (11), p.1634-1639

2010

Volltextzugriff (PDF)

Natural History of Mild and of Moderate Aortic Stenosis—New Insights From a Large Prospective European Study

Current problems in cardiology, 2013-09, Vol.38 (9), p.365-409

2013

Volltextzugriff (PDF)

Usefulness of the Electrocardiogram in Predicting Cardiovascular Mortality in Asymptomatic Adults With Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

The American journal of cardiology, 2014-09, Vol.114 (5), p.751-756

2014

Volltextzugriff (PDF)

Factors Influencing Left Ventricular Structure and Stress-Corrected Systolic Function in Men and Women With Asymptomatic Aortic Valve Stenosis (a SEAS Substudy)

The American journal of cardiology, 2008-02, Vol.101 (4), p.510-515

2008

Volltextzugriff (PDF)

Differences in Cardiovascular Risk Profile Between Electrocardiographic Hypertrophy Versus Strain in Asymptomatic Patients With Aortic Stenosis (from SEAS Data)

The American journal of cardiology, 2011-08, Vol.108 (4), p.541-547

2011

Volltextzugriff (PDF)

Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study

The American heart journal, 2012-04, Vol.163 (4), p.690-696

2012

Volltextzugriff (PDF)

Left Atrial Volume in Patients With Asymptomatic Aortic Valve Stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis Study)

The American journal of cardiology, 2008-04, Vol.101 (7), p.1030-1034

2008

Volltextzugriff (PDF)

Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy)

The American journal of cardiology, 2009-10, Vol.104 (8), p.1098-1104

2009

Volltextzugriff (PDF)

Global systolic load, left ventricular hypertrophy, and atrial fibrillation

The American heart journal, 2012-10, Vol.164 (4), p.e13-e13

2012

Volltextzugriff (PDF)

Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.1142-1149

2012

Volltextzugriff (PDF)

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

Journal of the American College of Cardiology, 2010-05, Vol.55 (21), p.2299-2307

2010

Volltextzugriff (PDF)

Low-Flow Aortic Stenosis in Asymptomatic Patients

JACC. Cardiovascular imaging, 2009-04, Vol.2 (4), p.390-399

2009

Volltextzugriff (PDF)

Prevalence and Prognostic Implications of ST-Segment Deviations from Ambulatory Holter Monitoring After ST-Segment Elevation Myocardial Infarction Treated With Either Fibrinolysis or Primary Percutaneous Coronary Intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy)

The American journal of cardiology, 2007-09, Vol.100 (6), p.937-943

2007

Volltextzugriff (PDF)

Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study

The American journal of cardiology, 2007-04, Vol.99 (7), p.970-973

2007

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

suPAR: A New Biomarker for Cardiovascular Disease?

Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy

Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial

When to Operate: Severe Aortic Stenosis Is Still a Clinical Enigma

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Structural and Functional Cardiac Changes Are Target Organ Damage That Increases Risk of Atrial Fibrillation

Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)

Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study)

Natural History of Mild and of Moderate Aortic Stenosis—New Insights From a Large Prospective European Study

Usefulness of the Electrocardiogram in Predicting Cardiovascular Mortality in Asymptomatic Adults With Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Factors Influencing Left Ventricular Structure and Stress-Corrected Systolic Function in Men and Women With Asymptomatic Aortic Valve Stenosis (a SEAS Substudy)

Differences in Cardiovascular Risk Profile Between Electrocardiographic Hypertrophy Versus Strain in Asymptomatic Patients With Aortic Stenosis (from SEAS Data)

Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study

Left Atrial Volume in Patients With Asymptomatic Aortic Valve Stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy)

Global systolic load, left ventricular hypertrophy, and atrial fibrillation

Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

Low-Flow Aortic Stenosis in Asymptomatic Patients

Prevalence and Prognostic Implications of ST-Segment Deviations from Ambulatory Holter Monitoring After ST-Segment Elevation Myocardial Infarction Treated With Either Fibrinolysis or Primary Percutaneous Coronary Intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy)

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension

Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study

Suchergebnisse filtern